Date updated:02-09-2007
No description available

-
MRK
Merck & Company - $38.08
- +0.37%
- $37.99
No Analysis added

-
TGT
Target Corporatio - $53.44
- -0.06%
- $53.50
No Analysis added

-
WAG
Walgreen Company - $34.48
- -0.09%
- $34.57
No Analysis added

-
DIS
Walt Disney Compa - $33.75
- 0.00%
- $33.79
No Analysis added

-
MET
Metlife - $43.03
- +0.80%
- $43.03
No Analysis added

-
WLP
Wellpoint - $61.94
- -0.05%
- $62.15
No Analysis added

-
GE
General Electric - $18.04
- -0.17%
- $18.33
No Analysis added
- mawother drip's Blog
- No Blogs Found
- Top Professional Portfolios
- 1. Fidelity Contrafund - ...
- 2. Fidelity Select Pharma...
- 3. Calamos Advisors
- 4. ProFunds Pharmaceutica...
- 5. BlackRock Health Scien...
- show all
- Top Do-It-Yourself Portfolios
- » jgroov Portfolio 1
- » ben johnson
- » my holdings
- » SC TRADE OF THE DAY
- » kudos
- show all
- Most Viewed Portfolios
- » Warren Buffett
- » George Soros
- » T. Boone Pickens - BP Cap...
- » Carl Icahn
- » Renaissance Technologies
- show all
Posted on March 17, 2010 Regardless of why a stock is in the news, it never hurts to hear what a professional investor has to say about it. The key is to gather as much ...
By Jonas Elmerraji Posted on March 17, 2010 Investors have always had a love/hate relationship with so-called “sin stocks” -- companies that operate businesses that...
By Jonas Elmerraji Posted on March 16, 2010 This week could prove to be an interesting one for market participants as the S&P 500 index struggles to push up against 52-...
By Roberto Pedone Posted on March 15, 2010 Large-Cap Quality Players: Barron’s talks with Steven Gorham and Nevin Chitkara, portfolio managers of the 14-year-old MFS ...
A. The only one I own : SLX,
too hard pick a winner out all of them
Here are some stocks that moved up on unusual volume on Mar. 17, 2010. more
Here is a list of some of the companies that will report earnings on Thursday, Mar. 18, 2010. For some of the companies below, we provide average EPS estimates from analys... more
TheStreet Ratings provides exclusive stock, ETF and mutual fund ratings and commentary based on award-winning, proprietary tools. Its saftey first approach to investing aim... more











Comments not available